85% effective in preventing severe/critical COVID-19 occurring at least 28 days after vaccination.
26 February 202111 July 2021
Is One Vaccine Dose Enough After COVID-19 Infection?
10 February 202114 November 2022
European Medicines Agency: clarification on Sputnik V vaccine in the EU approval process
The Sputnik V developers have received scientific advice from EMA providing them with the latest regulatory and scientific guidance for the development of their vaccine
3 February 202114 November 2022
New Variants of the Virus that Causes COVID-19
Viruses constantly change through mutation, and new variants of a virus are expected to occur over time
1 February 202114 November 2022
Safe COVID-19 vaccines for Europeans
Contracts have been concluded with 6 promising vaccine developers, securing a portfolio of more than 2.3 billion doses. By summer 2021, Member States should have vaccinated a minimum of 70% of the entire adult population.
29 January 202111 July 2021
European Commission authorises AstraZeneca, the third safe and effective vaccine against COVID-19
The vaccine causes the immune system (the body's natural defences) to produce antibodies and specialised white blood cells that work against the virus, so giving protection against COVID-19.
12 January 202122 February 2021
Breathlessness after COVID-19
The feeling of shortness of breath may continue for a while after your illness. This is a normal part of the recovery process.
6 January 202111 July 2021
COVID-19 Vaccine Moderna is now authorised across the EU. This follows the granting of a conditional marketing authorisation by the European Commission
A very large clinical trial showed that COVID-19 Vaccine Moderna was effective at preventing COVID-19 in people from 18 years of age.